GRI Bio, Inc.

GRI Bio, Inc.verified

GRI

Price:

$2.25

Market Cap:

$202.12K

GRI Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutic agents within the United States. Its primary focus lies in addressing inflammatory, fibrotic, and autoimmune disorders. The company's leading drug candidate is GRI-0621, an oral inhibitor targeting type 1 Natural Killer T cells, which is currently undergoing Phase IIa clinical trials. This investigational treatment is being evaluated for severe fibrotic lung conditions, including idiopathic pulmonary fibrosis. Beyond its flagship program, GRI Bio's pipeline also features GRI-0803, a novel oral agonist designed to activate type 2 Natural Killer T cells, cur...[Read more]

Industry

Biotechnology

IPO Date

2023-04-24

Stock Exchange

NASDAQ

Ticker

GRI

The Enterprise Value as of June 2026 (TTM) for GRI Bio, Inc. (GRI) is -10787878.00

According to GRI Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -10787878.00. This represents a change of 163.10% compared to the average of -4100372.96 of the last 4 quarters.

GRI Bio, Inc. (GRI) Historical Enterprise Value (quarterly & annually)

How has GRI Enterprise Value performed in the past?

The mean historical Enterprise Value of GRI Bio, Inc. over the last ten years is 14.63B. The current -10787878.00 Enterprise Value has changed -107.38% with respect to the historical average. Over the past ten years (40 quarters), GRI's Enterprise Value was at its highest in in the December 2020 quarter at 8.80B. The Enterprise Value was at its lowest in in the March 2026 quarter at -8148110.00.

Quarterly (TTM)
Annual

Average

14.63B

Median

4.62B

Minimum

-7479700.58

Maximum

90.16B

GRI Bio, Inc. (GRI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GRI Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 924.59%

Maximum Annual Enterprise Value = 90.16B

Minimum Annual Increase = -109.50%

Minimum Annual Enterprise Value = -7479700.58

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-7479700.58221.25%
2024-2328304.96-109.50%
202324.52M-94.40%
2022437.81M-99.51%
202190.16B924.59%
20208.80B0.04%
20198.80B-0.03%

GRI Bio, Inc. (GRI) Average Enterprise Value

How has GRI Enterprise Value performed in the past?

The current Enterprise Value of GRI Bio, Inc. (GRI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.90M

5-year avg

18.12B

10-year avg

14.63B

GRI Bio, Inc. (GRI) Enterprise Value vs. Peers

How is GRI’s Enterprise Value compared to its peers?

GRI Bio, Inc.’s Enterprise Value is less than CNS Pharmaceuticals, Inc. (91.17K), less than Jaguar Health, Inc. (27.21M), less than Silo Pharma, Inc. (2.10M), less than Biodexa Pharmaceuticals Plc (-6777847.98), less than Abpro Corporation (-4541200.00), less than InMed Pharmaceuticals Inc. (-2005797.00), less than Can-Fite BioPharma Ltd. (7.43B), less than 60 Degrees Pharmaceuticals, Inc. (-2088883.00), greater than Genprex, Inc. (-17004550.00), less than Calidi Biotherapeutics, Inc. (-3842430.00),

Build a custom stock screener for GRI Bio, Inc. (GRI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GRI Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GRI Bio, Inc. (GRI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GRI Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is GRI Bio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for GRI Bio, Inc. (GRI)?

What is the 3-year average Enterprise Value for GRI Bio, Inc. (GRI)?

What is the 5-year average Enterprise Value for GRI Bio, Inc. (GRI)?

How does the current Enterprise Value for GRI Bio, Inc. (GRI) compare to its historical average?